Eupraxia Pharmaceuticals Inc (EPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 7,482 | 6,273 | 6,555 | 6,694 | 12,177 |
| Operating Income | -7,482 | -6,273 | -6,555 | -6,694 | -12,177 |
| Interest Expense | 0 | 1 | 282 | 321 | 257 |
| Other Income | -49 | 282 | 768 | 863 | 1,862 |
| Pre-tax Income | -7,531 | -5,991 | -6,069 | -6,152 | -10,572 |
| Income Tax | -8 | N/A | 5 | 5 | 36 |
| Net Income Continuous | -7,522 | -5,991 | -6,074 | -6,157 | -4,096 |
| Minority Interests | -23 | -48 | -57 | -114 | -380 |
| Net Income | $-7,509 | $-5,943 | $-6,007 | $-6,043 | $-4,096 |
| EPS Basic Total Ops | -0.21 | -0.17 | -0.17 | -0.21 | -0.17 |
| EPS Basic Continuous Ops | -0.21 | -0.17 | -0.17 | -0.21 | -0.17 |
| EPS Diluted Total Ops | -0.21 | -0.17 | -0.17 | -0.21 | -0.17 |
| EPS Diluted Continuous Ops | -0.21 | -0.17 | -0.17 | -0.21 | -0.17 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.17 | -0.17 | N/A | N/A |
| EBITDA(a) | $-7,427 | $-6,236 | $-6,513 | $-6,656 | $-12,136 |